Related Experiment Videos
A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry--2.
1Department of Clinical Pharmacokinetics, Glaxo Inc., Research Triangle Park, NC 27709.
Journal of Pharmaceutical and Biomedical Analysis
|January 1, 1991
Summary
This study details statistical analyses for bioanalytical method validation, ensuring reliability and reproducibility. Continuous monitoring of quality control data confirms accurate sample concentration reporting over time.
Area of Science:
- Pharmaceutical Analysis
- Analytical Chemistry
- Biotechnology
Background:
- Bioanalytical method validation is crucial for reliable drug development.
- A previous paper outlined a general validation strategy.
- This paper specifically addresses the statistical analysis of validation data.
Purpose of the Study:
- To present statistical methods for evaluating bioanalytical method reliability and reproducibility.
- To establish acceptance criteria for quality control (QC) concentrations during analytical runs.
- To describe a continuous validation process for ongoing method performance monitoring.
Main Methods:
- Statistical analysis of bioanalytical validation data.
- Establishment of acceptance criteria for QC concentrations.
- Incorporation of QC results into databases for updating acceptance limits.
Main Results:
- Statistical analyses provide a basis for assessing method reliability.
- Defined acceptance criteria ensure the validity of analytical runs.
- Continuous validation allows for monitoring method performance over time.
Conclusions:
- Statistical analysis is essential for evaluating bioanalytical method performance.
- A continuous validation approach enhances confidence in reported sample concentrations.
- Analysts must use sound judgment when interpreting statistical data for method reliability.